Laobaixing Pharmacy (603883) — Strategic Asset Allocation Index
Laobaixing Pharmacy (603883) has a Strategic Asset Allocation Index of 59.1% as of June 2023. Strategic assets (PP&E of CN¥4.35 Billion plus long-term investments of CN¥-) total CN¥4.35 Billion, measured against net assets of CN¥7.36 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Laobaixing Pharmacy Strategic Asset Allocation Index (2012–2021)
This chart shows how Laobaixing Pharmacy's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 59.1%, representing strategic assets of CN¥4.35 Billion against net assets of CN¥7.36 Billion CNY. Explore 603883 cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Laobaixing Pharmacy (2012–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Laobaixing Pharmacy from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Laobaixing Pharmacy market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 97.8% | CN¥4.67 Billion | CN¥4.67 Billion | CN¥- | CN¥4.78 Billion | ▲ +75.3 pp |
| 2020 | 22.5% | CN¥1.08 Billion | CN¥1.08 Billion | CN¥- | CN¥4.81 Billion | ▼ -3.1 pp |
| 2019 | 25.6% | CN¥993.25 Million | CN¥993.25 Million | CN¥- | CN¥3.87 Billion | ▼ -0.4 pp |
| 2018 | 26.0% | CN¥875.73 Million | CN¥807.39 Million | CN¥68.34 Million | CN¥3.37 Billion | ▲ +12.0 pp |
| 2017 | 14.0% | CN¥433.81 Million | CN¥433.81 Million | CN¥- | CN¥3.10 Billion | ▲ +0.2 pp |
| 2016 | 13.8% | CN¥268.78 Million | CN¥268.78 Million | CN¥- | CN¥1.95 Billion | ▲ +4.6 pp |
| 2015 | 9.3% | CN¥212.12 Million | CN¥212.12 Million | CN¥- | CN¥2.29 Billion | ▼ -8.9 pp |
| 2014 | 18.2% | CN¥197.13 Million | CN¥197.13 Million | CN¥- | CN¥1.09 Billion | ▼ -0.5 pp |
| 2013 | 18.7% | CN¥170.96 Million | CN¥170.96 Million | CN¥- | CN¥916.46 Million | ▲ +0.4 pp |
| 2012 | 18.3% | CN¥133.93 Million | CN¥133.93 Million | CN¥- | CN¥732.59 Million | — |